You should read the following summary together with the more detailed business
information and consolidated financial statements and related notes that appear
elsewhere in this Form 10-K and in the documents that we incorporate by
reference into this Form 10-K. This document may contain certain
"forward-looking" information within the meaning of the Private Securities
Litigation Reform Act of 1995. This information involves risks and
uncertainties. Our actual results may differ materially from the results
discussed in the forward-looking statements. In this Form 10-K, (a) "FY" means
fiscal year; thus for example, FY23 refers to the fiscal year ended January 31,
2023 and (b) "Q" refers to a quarter; thus, for example, Q4 FY23 refers to the
fourth quarter of the fiscal year ended January 31, 2023.
Overview
We manufacture and sell a comprehensive line of industrial protective clothing
and accessories for the industrial and public protective clothing market. Our
products are sold globally by our in-house sales teams, our customer service
group, and authorized independent sales representatives to a network of over
1,600 global safety and industrial supply distributors. Our authorized
distributors supply end users, such as integrated oil, chemical/petrochemical,
automobile, steel, glass, construction, smelting, cleanroom, janitorial,
pharmaceutical, and high technology electronics manufacturers, as well as
scientific, medical laboratories and the utilities industry. In addition, we
supply federal, state and local governmental agencies and departments, such as
fire and law enforcement, airport crash rescue units, the Department of Defense,
the Department of Homeland Security and the Centers for Disease Control.
Internationally, we sell to a mixture of end users directly and to industrial
distributors depending on the particular country and market. In addition to the
United States, sales are made to more than 50 foreign countries, the majority of
which were into China, countries within the European Economic Community ("EEC"),
Canada, Chile, Argentina, Russia, Kazakhstan, Colombia, Mexico, Ecuador, India,
Middle East and countries within Southeast Asia.
We had net sales of $112.8 million in FY23 and $118.4 million in FY22.
We have operated facilities in Mexico since 1995 and in China since 1996.
Beginning in 1995, we moved the labor intensive sewing operation for our limited
use/disposable protective clothing lines to these facilities. Our facilities and
capabilities in China and Mexico allow access to a less expensive labor pool
than is available in the United States and permit us to purchase certain raw
materials at a lower cost than they are available domestically. During FY23, the
Company was impacted by tariff costs on certain products imported from China.
The Company has been able to pass along a portion of these costs to its
customers. We added manufacturing operations in Vietnam and India in fiscal 2019
to offset increasing manufacturing costs in China and further diversify our
manufacturing capabilities. Our China operations will continue primarily
manufacturing for the Chinese market and other markets where duty advantages
exist. Manufacturing expansion is not only necessary to control rising costs, it
is also necessary for Lakeland to achieve its growth objectives.
Our net sales attributable to customers outside the United States were $63.9
million and $70.8 million for the fiscal years ended January 31, 2023 and 2022,
respectively.
On December 2, 2022, we acquired UK-based Eagle Technical Products Limited
("Eagle") in an all-cash transaction valued at approximately $10.5 million
subject to post-closing adjustments and potential future earnout payments. The
acquisition enhances Lakeland's product portfolio, particularly within fire
service protective clothing and expands its sales presence in the Middle East
and Europe. Headquartered in Manchester, UK, Eagle is a leading designer and
provider of protective apparel to the fire and industrial sectors. Eagle
provides differentiated product offerings through its innovative and technical
solutions.
The cost to manufacture and distribute our products is influenced by the cost of
raw materials, finished goods, labor, and transportation. During FY23, we have
experienced continued inflationary pressure and higher costs as a result of the
increasing cost of raw materials, finished goods, labor, transportation, and
other administrative costs associated with the normal course of business. The
increase in cost of raw materials and finished goods are due in part to a
shortage in the availability of certain products, the higher cost of shipping,
and inflation. We can only pass elevated costs onto customers in an effort to
offset inflationary pressures on a limited basis. Future volatility of general
price inflation and the impact of inflation on costs and availability of
materials, costs for shipping and warehousing and other operational overhead
could adversely affect our financial results.
22
Table of Contents
Impact of Russia's Invasion of Ukraine on Our Business
The current conflict between Russia and Ukraine is creating substantial
uncertainty about the role Russia will play in the global economy in the future.
Although the length, impact and outcome of the ongoing military conflict between
Russia and Ukraine is highly unpredictable, this conflict could lead to
significant market and other disruptions. The escalation or continuation of this
conflict presents heightened risks and has resulted and could continue to result
in volatile commodity markets, supply chain disruptions, increased risk of cyber
incidents or other disruptions to information systems, heightened risks to
employee safety, significant volatility of the Russian ruble, limitations on
access to credit markets, increased operating costs (including fuel and other
input costs), the frequency and volume of failures to settle securities
transactions, inflation, potential for increased volatility in commodity,
currency and other financial markets, safety risks, and restrictions on the
transfer of funds to and from Russia. We cannot predict how and the extent to
which the conflict will affect our customers, operations or business partners or
the demand for our products and our global business. Depending on the actions we
take or are required to take, the ongoing conflict could also result in loss of
cash, assets or impairment charges. Additionally, we may also face negative
publicity and reputational risk based on the actions we take or are required to
take as a result of the conflict, which could damage our brand image or
corporate reputation. We are continually monitoring the potential financial
impact of the Russian invasion of Ukraine on our operations.
Our business in Russia accounted for approximately 2.4% and 2.5% of our
consolidated net revenues and 1.9% and 3.0% of our net income for the years
ended January 31, 2023 and 2022, respectively. Our assets in Russia were
approximately 2.5% and 2.1% of our consolidated assets at January 31, 2023 and
2022, respectively. The net book value of our assets in Russia at January 31,
2023 was approximately $3.5 million of which $1.3 million is cash. We currently
have not recognized any impairment charges related to the assets of our Russian
business. However, the extent, severity, duration and outcome of the conflict
between Russia and Ukraine and related sanctions could potentially impact the
value of our assets in Russia as the conflict continues. Our Russian business is
part of our Other Foreign segment.
Our sales into Ukraine were not significant.
COVID-19
The COVID-19 pandemic has had, and continues to have, a significant impact
around the world, prompting governments and businesses to take unprecedented
measures, such as restrictions on travel and business operations, temporary
closures of businesses, and quarantine and shelter-in-place orders. The COVID-19
pandemic has at times significantly curtailed global economic activity and
caused significant volatility and disruption in global financial markets. The
COVID-19 pandemic and the measures taken by many countries in response have
affected and could in the future materially impact the Company's business,
results of operations and financial condition.
Certain of the Company's materials suppliers and logistical service providers
have experienced disruptions during the COVID-19 pandemic, resulting in supply
shortages. Similar disruptions could occur in the future.
Critical Accounting Policies and Estimates
Revenue Recognition. Substantially all the Company's revenue is derived from
product sales, which consist of sales of the Company's personal protective wear
products to distributors. The Company considers purchase orders to be a contract
with a customer. Contracts with customers are considered to be short-term when
the time between order confirmation and satisfaction of the performance
obligations is equal to or less than one year, and virtually all of the
Company's contracts are short-term. The Company recognizes revenue for the
transfer of promised goods to customers in an amount that reflects the
consideration to which the Company expects to be entitled in exchange for those
goods. The Company typically satisfies its performance obligations in contracts
with customers upon shipment of the goods. Generally, payment is due from
customers within 30 to 90 days of the invoice date, and the contracts do not
have significant financing components. The Company elected to account for
shipping and handling activities as a fulfillment cost rather than a separate
performance obligation. Shipping and handling costs associated with outbound
freight are included in operating expenses, and for the years ended in FY23 and
FY22 aggregated approximately $3.2 million and $2.9 million, respectively. Taxes
collected from customers relating to product sales and remitted to governmental
authorities are excluded from revenue.
The transaction price includes estimates of variable consideration, related to
rebates, allowances, and discounts that are reductions in revenue. All estimates
are based on the Company's historical experience, anticipated performance, and
the Company's best judgment at the time the estimate is made. Estimates for
variable consideration are reassessed each reporting period and are included in
the transaction price to the extent it is probable that a significant reversal
of cumulative revenue recognized will not occur upon resolution of uncertainty
associated with the variable consideration. All the Company's contracts have a
single performance obligation satisfied at a point in time and the transaction
price is stated in the contract, usually as quantity times price per unit.
23
Table of Contents
Inventories. Inventories include freight-in, materials, labor and overhead costs
and are stated at the lower of cost (on a first-in, first-out or moving average
basis) or net realizable value. Allowances are recorded for slow-moving,
obsolete or unusable inventory. We assess our inventory for estimated
obsolescence or unmarketable inventory and write down the difference between the
cost of inventory and the estimated net realizable value based upon assumptions
about future sales and supply on-hand, if necessary. If actual market conditions
are less favorable than those projected by management, additional inventory
write-downs may be required. In FY23 we recorded approximately $1.3 million in
write-downs of inventory and $0.6 million in inventory adjustments in FY22.
Income Taxes. The Company is required to estimate its income taxes in each of
the jurisdictions in which it operates as part of preparing the consolidated
financial statements. This involves estimating the actual current tax in
addition to assessing temporary differences resulting from differing treatments
for tax and financial accounting purposes. These differences, together with net
operating loss carryforwards and tax credits, are recorded as deferred tax
assets or liabilities on the Company's consolidated balance sheet. A judgment
must then be made of the likelihood that any deferred tax assets will be
recovered from future taxable income. A valuation allowance may be required to
reduce deferred tax assets to the amount that is more likely than not to be
realized. In the event the Company determines that it may not be able to realize
all or part of its deferred tax asset in the future, or that new estimates
indicate that a previously recorded valuation allowance is no longer required,
an adjustment to the deferred tax asset is charged or credited to income in the
period of such determination. In FY23 and FY22, we recorded a valuation
allowance of approximately $0.4 million and $0.8 million, respectively.
The Company recognizes tax positions that meet a "more likely than not" minimum
recognition threshold. If necessary, the Company recognizes interest and
penalties associated with tax matters as part of the income tax provision and
would include accrued interest and penalties with the related tax liability in
the consolidated balance sheets.
Business combinations. In accordance with the accounting guidance for business
combinations, the Company uses the acquisition method of accounting to allocate
costs of acquired businesses to the assets acquired and liabilities assumed
based on their estimated fair values at the dates of acquisition. The excess of
the purchase price over the estimated fair value of assets and liabilities is
recorded as goodwill. Assigning fair market values to the assets acquired and
liabilities assumed at the date of an acquisition requires knowledge of current
market values, the values of assets in use, and often requires the application
of judgment regarding estimates and assumptions. While the ultimate
responsibility resides with management, for material acquisitions we retain the
services of certified valuation specialists to assist with assigning estimated
values to certain acquired assets and assumed liabilities, including intangible
assets, tangible long-lived assets, and contingent consideration. Acquired
intangible assets, excluding goodwill, are valued using certain discounted cash
flow methodologies based on future cash flows specific to the type of intangible
asset purchased. Several significant assumptions and estimates were involved in
the application of these valuation methods, including forecasted sales volumes
and prices, royalty rates, costs to produce, tax rates, discount rates,
attrition rates and working capital changes.
If the contingent consideration is deemed significant or absent an agreed upon
payout amount, the initial measurement of contingent consideration and the
corresponding liability is evaluated using the Monte Carlo Method. For this
valuation method, management develops projections during the contingent
consideration period utilizing various potential pay-out scenarios.
Probabilities are applied to each potential scenario and the resulting values
are discounted using a rate that considers weighted average cost of capital as
well as a specific risk premium associated with the riskiness of the contingent
consideration itself, the related projections, and the overall business. Should
actual results increase or decrease as compared to the assumption used in our
analysis, the fair value of the contingent consideration obligations will
increase or decrease, up to the contracted limit, as applicable. Changes in the
fair value of the contingent earn-out consideration could cause a material
impact and volatility in our operating results.
Refer to Note 1, "Business and Summary of Significant Accounting Policies," and
Note 5, "Acquisitions," to the consolidated financial statements in Item 8 of
this Annual Report on Form 10-K for further information on the Company's
business acquisitions.
Net Income Per Share. Basic net income per share is based on the weighted
average number of common shares outstanding without consideration of common
stock equivalents. Diluted net income per share is based on the weighted average
number of common shares and common stock equivalents. The diluted net income per
share calculation takes into account unvested restricted shares and the shares
that may be issued upon exercise of stock options and warrants, reduced by
shares that may be repurchased with the funds received from the exercise, based
on the average price during the fiscal year.
24
Table of Contents
Significant Balance Sheet Fluctuation January 31, 2023, as Compared to January
31, 2022
Cash decreased by $28.1 million, primarily as a result of $5.5 million of cash
used in operations coupled with $5.4 million in share repurchases, $10.5 million
for the acquisition of Eagle, $3.1 million in equity investment and $2.0 million
in capital improvements. Operating cash flow changes were driven by an increase
in accounts receivable of $2.3 million due to timing of collections, increased
sales in Q4 FY23 over Q4 FY22 and the acquisition of Eagle in December
FY23. Excluding inventory acquired from Eagle, inventory increased $9.7 million
driven by investment in inventory to reduce the impact on our supply chain of a
global slowdown in freight deliveries.
The Company has made strategic investments of $6.1 million in Inova Design
Solutions Ltd. (doing business as Bodytrak®) as a groundbreaking step toward
entering the Connected Worker Market for "Smart PPE." Bodytrak's unique
ear-based sensor platform uses precise physiological measurements and
cloud-based analytics to automate health, safety and performance monitoring,
making it an ideal complement to Lakeland's portfolio of industrial protective
solutions.
Results of Operations
The following tables set forth our external sales by our product lines, and
geographic regions and our historical results of continuing operations as a
percentage of our net sales from operations, for the years and three-months
ended January 31, 2023 and 2022.
Three Months Ended January 31,
(Unaudited) Year Ended January 31,
2023 2022 2023 2022
External Sales by
Product Line:
Disposables $ 13.9 $ 14.1 $ 55.2 $ 67.2
Chemical 4.8 5.5 22.2 24.5
Fire 5.5 2.3 14.7 8.2
Gloves 0.5 0.5 2.3 2.2
High Visibility 1.2 1.8 5.8 5.6
High Performance
Wear 1.2 0.9 5.0 3.6
Wovens 1.9 1.7 7.6 7.1
Consolidated
external sales $ 29.0 $ 26.8 $ 112.8 $ 118.4
25
Table of Contents
Three Months Ended January 31,
(Unaudited) Year Ended January 31,
2023 2022 2023 2022
External Sales by
region:
USA $ 11.9 $ 11.2 $ 49.0 $ 47.6
Other foreign 1.8 2.1 7.2 7.1
Europe (UK) 3.0 1.5 8.3 10.3
Mexico 0.8 0.8 3.7 4.1
Asia 5.6 7.4 24.7 29.8
Canada 2.1 1.4 9.1 8.2
Latin America 3.8 2.4 10.8 11.3
Consolidated
external sales $ 29.0 $ 26.8 $ 112.8 $ 118.4
Three Months Ended January 31,
(Unaudited) Year Ended January 31,
2023 2022 2023 2022
Net sales 100.0 % 100.0 % 100.0 % 100.0 %
Cost of goods sold 62.5 % 60.8 % 59.4 % 57.0 %
Gross profit 37.5 % 39.2 % 40.6 % 43.0 %
Operating expenses 37.2 % 35.0 % 35.7 % 29.5 %
Operating profit 0.3 % 4.2 % 4.9 % 13.6 %
Other income, net 0.3 % 0.5 % 0.0 % 0.1 %
Interest expense 0.0 % 0.0 % 0.1 % 0.0 %
Income before tax 0.6 % 4.7 % 4.8 % 13.7 %
Income tax expense (0.0 %) 2.8 % 3.2 % 4.1 %
Net income 0.6 % 1.9 % 1.6 % 9.6 %
Net Sales. Net sales decreased to $112.8 million for the year ended January 31,
2023 compared to $118.4 million for the year ended January 31, 2022, a decrease
of $5.6 million. Sales in the U.S. increased $1.4 million or 2.9%, primarily due
to increases in sales of fire gear coupled with improvements in direct container
sales. Sales to the Asian market decreased by $5.1 million or 17.1% due to the
impacts of COVID-19 on demand, including shutdowns in China and the absence of
typical year-end stocking ahead of the Chinese New Year due to the country's
"Zero COVID Policy." Sales to the European market decreased by $2.0 million or
19.4%, driven by reduced demand across Europe and a stronger dollar impact
offset by Eagle sales of $1.3 million in Q4 FY23. Canada sales increased by $0.9
million or 11.0% due to improvements in the industrial markets. Latin America
sales decreased $0.5 million or 4.4% due to weaker local currency, primarily the
Argentine peso. Sales into the Mexican market decreased by $0.4 million or 9.8%,
driven by weaker industrial demand at the beginning of FY23. Sales of our
disposable and chemical product line were impacted due to a reduction in
COVID-19 demand, primarily in Asia and uneven demand from our industrial
markets. Other product lines, such as fire, high performance, and wovens,
increased by $8.7 million due to strengthening demand in those markets and the
impact of Eagle's sales during the last two months of our fiscal year. Sales
were affected by customers over-ordering in prior periods, resulting in excess
channel inventories and shipping delays with ocean freight carriers.
Gross Profit. Gross profit decreased $5.1 million, or 10.0%, to $45.8 million
for the year ended January 31, 2023, from $50.9 million for the year ended
January 31, 2022. Gross profit as a percentage of net sales decreased to 40.6%
for the year ended January 31, 2023 from 43.0% for the year ended January 31,
2022. Gross profit performance in FY22 benefited from higher volumes including
direct container shipments, related factory utilization and an improving product
mix with pricing power. Major factors driving the decline in gross margins in
FY23, were:
· Inflationary pressure on certain materials
· Stronger dollar impacting revenue in key Asian and Latin American markets
· Pricing pressure on non-strategic products
· Writedown of the carrying value of certain inventory as freight rates
declined toward year-end
26
Table of Contents
Operating Expense. Operating expenses increased 15.6% from $34.9 million for the
year ended January 31, 2022 to $40.3 million for the year ended January 31,
2023. Operating expenses as a percentage of net sales were 35.7% for the year
ended January 31, 2023, as compared to 29.5% for the year ended January 31,
2022. Operating expenses increased primarily due to increases in currency
translation expense of $1.9 million, acquisition costs associated with the Eagle
transaction of $0.6 million, restructuring costs of $0.4 million, increased
outbound freight of $0.3 million, administrative costs associated with the
start-up of the Monterrey, Mexico facility of $0.2 million, and increases in
professional expenses, primarily legal and accounting, to support future
initiatives.
Operating Profit. Operating profit decreased to $5.5 million for the year ended
January 31, 2023, from $16.0 million for the year ended January 31, 2022, due to
the impacts detailed above. Operating margin decreased to 4.9% for the year
ended January 31, 2023, compared to 13.6% for the year ended January 31, 2022.
Interest Expense. Interest expenses was less than $0.1 million for the year
ended January 31, 2023 compared to $0.1 million for the year ended January 31,
2022. The Company did not drawdown any of its available line of credit during
FY23.
Income Tax Expense. Income tax expense consists of federal, state and foreign
income taxes. Income tax expense was $3.6 million and included $0.2 million
associated with the GILTI component of the Tax Act of 2017 for the year ended
January 31, 2023, as compared to an income tax expense of $4.8 million and
included $0.7 million associated with the GILTI component of the Tax Act of 2017
for the year ended January 31, 2022. All international subsidiaries impacted the
GILTI component of income tax expense. The Company changed its permanent
reinvestment assertions for its Chinese operations during the second quarter due
to increased volatility of the Chinese yuan and an updated evaluation of
investment strategies. The Company recorded $2.0 million in withholding taxes
for a planned repatriation during FY23.
Net Income. Net income decreased to $1.9 million for the year ended January 31,
2023 from $11.4 million for the year ended January 31, 2022.
Fourth Quarter Results
Net sales and net income were $29.0 million and $0.6 million, respectively, for
Q4 FY23, as compared to $26.8 million and $0.5 million, respectively, for Q4
FY22.
Factors affecting Q4 FY23 results of operations included:
· Improvement in sales primarily in the fire and industrial markets and due
to the Eagle acquisition
· Pricing pressure on non-strategic products
· Margins were negatively impacted by product mix and currency and the
write-down of the carrying value of certain inventory as freight rates
declined toward year-end
Liquidity and Capital Resources
At January 31, 2023, cash and cash equivalents were approximately $24.6 million
and working capital was approximately $87.0 million. Cash and cash equivalents
decreased $28.1 million and working capital decreased $21.6 million from January
31, 2022 reflecting the impact of the Company's purchase of Eagle, additional
investment in Bodytrak and stock repurchases.
Of the Company's total cash and cash equivalents of $24.6 million as of January
31, 2023, cash held in Latin America of $1.8 million, cash held in Hong Kong of
$0.7 million, cash held in the UK of $2.4 million, cash held in Vietnam of $0.8
million, cash held in India of $0.7 million and cash held in Canada of $1.0
million would not be subject to additional US tax in the event such cash was
repatriated due to the change in the U.S. tax law as a result of the 2017 Tax
Cuts and Jobs Act (the "Tax Act"). The Company monitors its financial
depositories by their credit rating which varies by country. In addition, cash
balances in banks in the United States are insured by the FDIC subject to
certain limitations. There was approximately $1.3 million total included in the
U.S. bank accounts and approximately $23.5 million total in foreign bank
accounts as of January 31, 2023, of which $24.1 million was uninsured. These
balances could be impacted if one or more of the financial institutions with
which the Company deposits its funds fails or is subject to other adverse
conditions in the financial or credit markets. To date, the Company has
experienced no loss of principal or lack of access to invested cash or cash
equivalents; however, we can provide no assurance that access to our invested
cash and cash equivalents will not be affected if the financial institutions
that hold the Company's cash and cash equivalents fail. See Part I, Item 1A.
Risk Factors in this Annual Report on Form 10-K under the caption "Adverse
developments affecting the financial services industry, including events or
concerns involving liquidity, defaults or non-performance by financial
institutions or transactional counterparties, could adversely affect our
business, financial condition or results of operations."
27
Table of Contents
The Company strategically employs an intercompany dividend plan subject to
subsidiary profitability, cash requirements and withholding taxes. During FY23
the Company changed its' permanent reinvestment assertions for its Chinese
operations due to increased volatility of the Chinese yuan and an updated
evaluation of investment strategies. During FY23 the Company's subsidiaries in
Canada, China and Hong Kong declared and paid dividends of $1.0 million, $12.5
million and $2.0 million. Withholding taxes totaling $2.0 million are included
in income tax expense.
Net cash used in operating activities of $5.5 million for the year ended January
31, 2023 was primarily due to an increase in net inventories of $9.7 million and
an increase in accounts receivable of $2.3 million due to stronger Q4 FY23
sales, partially offset by non-cash expenses of $3.6 million for deferred taxes,
depreciation and amortization, and stock compensation. Net cash used in
investing activities of $16.5 million for the year ended January 31, 2023
includes the $10.5 million Eagle acquisition and reflects the Company's $3.1
million investment in Bodytrak®. Purchases of property and equipment were $2.0
million as the Company increased capital expenditures in the year for the ERP
project and equipment purchases in Mexico and Vietnam. Net cash used in
financing activities was $5.9 million for the year ended January 31, 2023
primarily due to the purchase of $5.4 million of our common stock.
Net cash provided by operating activities of $12.8 million for the year ended
January 31, 2022 was primarily due to net income of $11.4 million, non-cash
expenses of $4.3 million for deferred taxes, depreciation and amortization, and
stock compensation, and a decrease in accounts receivable due to lower sales
activity of $6.7 million offset by an increase in net inventories of $4.4
million and a decrease in accounts payable, accrued expenses and other
liabilities of $5.2 million due to lower sales volume. Net cash used in
investing activities of $3.6 million for the year ended January 31, 2022
reflects the Company's $2.8 million investment in Bodytrak® as a groundbreaking
step toward entering the Connected Worker Market for "Smart PPE." Purchases in
property and equipment were $0.8 million as the Company made capital
expenditures in the year for the ERP project, leasehold improvements for our new
corporate headquarters, and equipment purchases in Mexico and China. Net cash
used in financing activities was $9.8 million for the year ended January 31,
2022 due to the purchase of $9.2 million of our common stock.
On June 25, 2020, we entered into a Loan Agreement (the "Loan Agreement") with
Bank of America ("Lender"). The Loan Agreement provides the Company with a
secured $12.5 million revolving credit facility, which includes a $5.0 million
letter of credit sub-facility. The Company may request from time to time an
increase in the revolving credit loan commitment of up to $5.0 million (for a
total commitment of up to $17.5 million). Borrowing pursuant to the revolving
credit facility is subject to a borrowing base amount calculated as (a) 80% of
eligible accounts receivable, as defined, plus (b) 50% of the value of
acceptable inventory, as defined, minus (c) certain reserves as the Lender may
establish for the amount of estimated exposure, as reasonably determined by the
Lender from time to time, under certain interest rate swap contracts. The
borrowing base limitation only applies during periods when the Company's
quarterly funded debt to EBITDA ratio, as defined, exceeds 2.00 to 1.00. The
credit facility will mature on June 25, 2025. Borrowings under the revolving
credit facility bear interest at a rate per annum equal to the sum of the LIBOR
Daily Floating Rate ("LIBOR"), plus 125 basis points. LIBOR is subject to a
floor of 100 basis points. On March 3, 2023 the Company changed the benchmark
interest rate in our credit facility from the LIBOR to the Secured Overnight
Financing Rate ("SOFR"). All outstanding principal and unpaid accrued interest
under the revolving credit facility is due and payable on the maturity date. On
a one-time basis, and subject to there not existing an event of default, the
Company may elect to convert up to $5.0 million of the then outstanding
principal of the revolving credit facility to a term loan facility with an
assumed amortization of 15 years and the same interest rate and maturity date as
the revolving credit facility. The Loan Agreement provides for an annual unused
line of credit commitment fee, payable quarterly, of 0.25%, based on the
difference between the total credit line commitment and the average daily amount
of credit outstanding under the facility during the preceding quarter.
On June 18, 2021, the Company entered into an Amendment No. 1 to Loan Agreement
(the "Amendment") with the Lender, which modifies certain terms of the Company's
existing Loan Agreement with the Lender. The Amendment increases the credit
limit under the Loan Agreement's senior secured revolving credit facility from
$12.5 million to $25.0 million. The Amendment also amends the covenant in the
Loan Agreement that restricts acquisitions by the Company or its subsidiaries in
order to allow, without the prior consent of the Lender, acquisitions of a
business or its assets if there is no default under the Loan Agreement and the
aggregate consideration does not exceed $7.5 million for any individual
acquisition or $15.0 million on a cumulative basis for all such acquisitions.
28
Table of Contents
The Loan Agreement requires the Company to maintain a Funded Debt to EBITDA (as
each such term is defined in the Loan Agreement) ratio of 3.0 to 1.0 or less and
a Basic Fixed Charge Coverage Ratio (as defined in the Loan Agreement) of at
least 1.15 to 1.0. The Loan Agreement also contains customary covenants,
including covenants that, among other things, limit or restrict the Company's
and/or the Company's subsidiaries ability, subject to certain exceptions and
qualifications, to incur liens or indebtedness, or merge, consolidate or sell or
otherwise transfer assets. The Company was in compliance with all of its debt
covenants as of January 31, 2023. As of January 31, 2023, the Company had no
borrowings under the Loan Agreement, and there was $25 million of additional
available credit under the Loan Agreement.
We believe that our current cash, cash equivalents, borrowing capacity under our
Loan Agreement and the cash to be generated from expected product sales will be
sufficient to meet our projected operating and investing requirements for at
least the next twelve months. However, our liquidity assumptions may prove to be
incorrect, and we could utilize our available financial resources sooner than we
currently expect.
Stock Repurchase Program. On February 17, 2021, the Company's board of directors
approved a stock repurchase program under which the Company may repurchase up to
$5 million of its outstanding common stock. On July 6, 2021, the Board of
Directors authorized an increase in the Company's stock repurchase program under
which the Company may repurchase up to an additional $5 million of its
outstanding common stock. On April 7, 2022, the Board of Directors authorized a
new stock repurchase program under which the Company may repurchase up to $5
million of its outstanding common stock which became effective upon the
completion of the prior share repurchase program. On December 1, 2022, the
Board of Directors authorized an increase in the Company's stock repurchase
program, under which the Company may repurchase up to an additional $5 million
of its outstanding common stock.
Shares repurchased in FY23 totaled 390,989 shares at a cost of $5.4 million
leaving $5.4 million remaining under the share repurchase program at January 31,
2023. The share repurchase program has no expiration date but may be terminated
by the Board of Directors at any time.
On February 1, 2023, the Board of Directors declared a quarterly cash dividend
as part of the initiation of a recurring quarterly dividend program. The initial
quarterly dividend of $0.03 per share was paid on February 22, 2023, to
stockholders of record as of February 15, 2023.
Capital Expenditures. Our capital expenditures for FY23 of $2.0 million
principally relate to our capital purchases for our manufacturing facilities in
Vietnam, the enhancement of IT infrastructure, and equipment purchases
supporting the new manufacturing facility under development in Monterey, Mexico.
We anticipate FY24 capital expenditures to be approximately $3.0 million as we
continue to deploy our ERP solution globally, complete the new manufacturing
facility in Monterrey, Mexico, and replace existing equipment in the normal
course of operations. We expect to fund the capital expenditures from our cash
flow from operations.
Recently Adopted and Recently Issued Accounting Standards
No recently issued accounting pronouncements had or are expected to have a
material impact on the Company's consolidated financial statements.
© Edgar Online, source Glimpses